Vision Loss Caused by GLP-1 Medications Must Be Answered For
Across the United States, patients have taken Ozempic, Wegovy, or Rybelsus trusting these medications to help manage diabetes or weight loss—without being warned of the risk of serious and permanent vision injuries. Reports now link these drugs to conditions such as NAION, eye stroke, and sudden vision loss, leaving patients shocked by life-altering consequences they never expected.
Our team understands the physical, emotional, and financial toll that sudden vision impairment can cause—not only for patients, but for their families as well. We are here to protect your rights, investigate whether proper warnings were given, and pursue accountability from the manufacturers responsible.
Taking legal action isn’t just about compensation—it’s about uncovering whether critical safety information was withheld and ensuring patients are fully informed of the risks before taking powerful medications.
If you or a loved one experienced vision loss after taking Ozempic, Wegovy, or Rybelsus, you may have the right to take action. Eligibility depends on factors such as diagnosis, timing, and medication use, but even recent diagnoses may qualify.
Together, we can seek answers, demand accountability, and help prevent others from suffering the same preventable harm.
We Handle Your Case with Confidentiality
We understand how overwhelming and personal vision loss can be—especially when it may be linked to a medication you trusted. Our team handles every case with complete confidentiality. Your personal information, medical details, and intake responses are kept private and are never publicly disclosed.
What You May Recover
By pursuing a vision loss claim related to Ozempic, Wegovy, or Rybelsus, you may be eligible to recover compensation for:
- Medical expenses related to diagnosis, treatment, and ongoing care
- Costs associated with vision loss, including assistive devices or therapy
- Lost wages or reduced earning capacity
- Pain, suffering, and diminished quality of life
- Potential additional damages if the manufacturer failed to provide adequate warnings